3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Multiple Myeloma
23
Lymphoma, Non-Hodgkin
19
Hodgkin Disease
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Leukemia, Myeloid, Acute
7
Lymphoma
6
Myelodysplastic Syndromes
5
Neoplasms, Plasma Cell
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Leukemia, Lymphocytic, Chronic, B-Cell
3
Hematologic Neoplasms
2
Sarcoma, Myeloid
1
Pancreatic Neoplasms
1
Lymphoma, T-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Plasma Cell
1
Leukemia, Myelomonocytic, Juvenile
1
Head and Neck Neoplasms
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Children Cancer, Solid Tumor
1
Interventions
plerixafor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Children Cancer, Solid Tumor
×
plerixafor
×
Clear all
NCT01225419
2014-07-08
MEP1
University Hospital, Clermont-Ferrand
Phase 2
Completed
5 enrolled